249 / 1578
/
Goals of high-tech RT
in the metastatic setting
M+
Cure
Synergy
with
systemic
Tx
Long term
symptom
control
Symptom
prevention
Prevention
of toxicity
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
25
07.09.17
/
„Mega“ trends & challenges in
Oncology
•
Aging population / increased comorbidities
•
Precision medicine / cancer as a chronic
disease
•
Tighter financial resources
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
26
07.09.17